Oxford, United Kingdom

Robert Crispin Carlisle

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2021

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Robert Crispin Carlisle

Introduction

Robert Crispin Carlisle is a notable inventor based in Oxford, GB. He has made significant contributions to the field of therapeutic and diagnostic agents. His innovative work focuses on enhancing the delivery of these agents through advanced methods.

Latest Patents

Carlisle holds a patent for a "Sonosensitive therapeutic or diagnostic agent." This invention relates to a method of cavitation-induced delivery of a therapeutic or diagnostic agent to a human or animal subject. The method involves exposing the subject to ultrasound, where the agent comprises a therapeutic or diagnostic component covalently bound to a dense component. This dense component, which has a greater density than the therapeutic or diagnostic component, enhances the transport of the therapeutic or diagnostic component through cavitation.

Career Highlights

Throughout his career, Carlisle has demonstrated a commitment to advancing medical technology. His work has the potential to improve diagnostic and treatment methods significantly. He is currently associated with Oxsonics Limited, where he continues to innovate in the field.

Collaborations

Carlisle has worked alongside notable colleagues such as Steven Mo and Leonard William Seymour. Their collaborative efforts contribute to the advancement of technology in the medical field.

Conclusion

Robert Crispin Carlisle's contributions to the field of therapeutic and diagnostic agents highlight his innovative spirit and dedication to improving medical practices. His patent on sonosensitive agents showcases the potential for enhanced treatment methods through technology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…